Results 41 to 50 of about 1,309,269 (176)

Efficacy of dual sublingual immunotherapy with Japanese cedar pollen and house dust mite allergens in patients with allergic rhinitis sensitized to multiple allergens

Laryngoscope Investigative Otolaryngology, Volume 7, Issue 1, Page 36-42, February 2022., 2022
Dual‐sublingual immunotherapy (SLIT) with Japanese cedar pollen and house dust mite was more effective in suppressing nasal obstruction at the peak pollen period than mono‐SLIT with Japanese cedar pollen. Abstract Objective In the present study, we examined the effects of dual sublingual immunotherapy (SLIT) with Japanese cedar pollen (JCP) and house ...
Tatsuya Fujii, Yoshiaki Kitamura, Seiichiro Kamimura, Keisuke Ishitani, Noriaki Takeda   +4 more
wiley   +1 more source

Therapeutic Efficacy of Flavonoids in Allergies: A Systematic Review of Randomized Controlled Trials

Journal of Immunology Research, Volume 2022, Issue 1, 2022., 2022
Objective. To assess the clinical efficacy of flavonoid supplements on allergic diseases. Design. Systematic review. Data Sources. MEDLINE/PubMed, Scopus, Web of Science, and Embase databases were searched from inception to September 2021. Eligibility Criteria for Selecting Studies.
Poliana Guiomar de Almeida Brasiel, Fernanda Verdini Guimarães, Patrícia Machado Rodrigues e Silva, Dumith Chequer Bou-Habib, Vinicius de Frias Carvalho, Payam Behzadi   +5 more
wiley   +1 more source

Molecular allergology and its impact in specific allergy diagnosis and therapy

Allergy, Volume 76, Issue 12, Page 3642-3658, December 2021., 2021
Abstract Progressive knowledge of allergenic structures resulted in a broad availability of allergenic molecules for diagnosis. Component‐resolved diagnosis allowed a better understanding of patient sensitization patterns, facilitating allergen immunotherapy decisions.
Domingo Barber, Araceli Diaz‐Perales, Maria M. Escribese, Jörg Kleine‐Tebbe, Paolo M. Matricardi, Markus Ollert, Alexandra F. Santos, Joaquin Sastre   +7 more
wiley   +1 more source

Japanese cedar pollinosis and HLA‐DP5

Tissue Antigens, 1996
Japanese cedar pollinosis is a type I allergic disease caused by Japanese cedar (Cryptomeria japonica) pollen. We investigated the association between the disease and HLA class II alleles by HLA‐DNA typing using a PCR‐SSOP method and found that the frequency of HLA‐DP5 (DPA1*02022 and DPB1*0501) was significantly increased in the patients.
T, Hori, N, Kamikawaji, A, Kimura, T, Sone, N, Komiyama, S, Komiyama, T, Sasazuki   +6 more
openaire   +3 more sources

Enhanced Production of IgE Anti-Japanese Cedar Pollen Specific Antibodies by Peripheral Blood B Cells from Patients with Japanese Cedar Pollinosis [PDF]

, 2008
BackgroundIgE antibodies against Japanese cedar pollen (JCP) play an important role for the pathogenesis of the cedar pollinosis, but the mechanism of their production has been unclear. We explored the capacity of peripheral blood B cells from pollinosis
Hirohata, Shunsei, Nobuharu Ohshima, Ohshima, Nobuharu, Shunsei Hirohata   +3 more
core   +1 more source

Sublingual Immunotherapy for Japanese Cedar Pollinosis

Nihon Bika Gakkai Kaishi (Japanese Journal of Rhinology), 2010
The prevalence of pollinosis caused by cedar pollen has increased by 10% these ten years of 26.5% in the investigation of 2008 in Japan. The pharmacotherapy is a main treatment tool for pollinosis, and the surgical treatment is not acknowledged to the treatment of pollinosis internationally.
Atsushi Yuta, Kei-ichi Yamanaka, Kimihiro Okubo   +2 more
openaire   +3 more sources

Same dose of Japanese cedar pollen sublingual immunotherapy tablets is optimal for allergic rhinitis caused by either Japanese cedar or Japanese cypress pollen

, 2023
Allergy, Volume 78, Issue 2, Page 563-568, February 2023.
Minoru Gotoh, Tomoya Kurokawa, Syuji Yonekura, Mitsuhiro Okano, Yuriko Maekawa, Yoshitaka Okamoto, Kimihiro Okubo   +6 more
wiley   +1 more source

Effect of modified immunotherapy with an allergen–pullulan conjugate in patients with Japanese cedar pollinosis [PDF]

, 2001
Immunologic mechanisms of allergen immunotherapy are still incompletely understood. Immunotherapy of a higher maximum tolerance dose with reduced risks of systemic reactions, such as anaphylaxis, needs to be developed. Seasonal allergic rhinitis (SAR) is
Goto, Yuichi, Nonaka, Manabu, Okuda, Minoru, Ohtsuka, Hirokuni, Pawankar, Ruby, Yagi, Toshiaki, Goto, Minoru, Takizawa, Ryuta, Yamagishi, Shigeo, Ohkubo, Kimihiro   +9 more
core   +1 more source

Effect of Antihistamine Eye Drops on the Conjunctival Provocation Test with Japanese Cedar Pollen Allergen

Allergology International, 2006
Background: Approximately 16.2% of the Japanese population suffer from cedar pollinosis, with various manifestations such as ophthalmic, laryngo-pharyngeal and skin symptoms in addition to nasal symptoms.
Yoshihiro Dake, Tadao Enomoto, Lei Cheng, Keisuke Enomoto, Akira Shibano, Hiroki Ikeda, Shigetoshi Yoda, Shinji Yajin, Takema Sakota, Emi Yamanishi   +9 more
doaj   +1 more source

Changes of Micro-RNAs in Asymptomatic Subjects Sensitized to Japanese Cedar Pollen after Prophylactic Sublingual Immunotherapy

Allergy & Rhinology, 2015
Japanese cedar pollinosis is the predominant seasonal allergic rhinitis in Japan, and it has increased in prevalence during the past 10 years. Sublingual immunotherapy (SLIT) is considered a safe and effective treatment for pollinosis. Micro-RNAs (miRNAs)
Bo Hou M.D., Mariko Murata M.D., Ph.D., Ahmad Shah Said M.D., Hiroshi Sakaida M.D., Ph.D., Sawako Masuda M.D., Ph.D., Taiki Takahashi, Zhe Zhang M.D., Ph.D., Kazuhiko Takeuchi M.D., Ph.D.   +7 more
doaj   +1 more source